Skip to content
Search

Latest Stories

‘Duty of Candour is not an add-on, it’s a fundamental part of pharmacy profession’

The General Pharmaceutical Council (GPhC) has developed two new resources- Keeping patients safe being open and honest and Pharmacy team toolkit – learning from incidents, to help pharmacists and pharmacy technicians fulfil the duty of candour – the professional responsibility to be open and honest with patients if/when something goes wrong.

The new resources bring together relevant existing policy, standards, and previous statements on the professional obligations of pharmacists and pharmacy technicians, with respect to candour.


It also emphasises that the duty of candour is not an add on – it’s a fundamental part of pharmacy professional practice.

The responsibility to be open and honest applies even in difficult or challenging times and it’s essential that professionals do the right thing for patients, their families and carers. Saying sorry meaningfully when things go wrong is vital for everyone involved.

Given the link with issues around liability and indemnity, the National Pharmacy Association and the Pharmacists’ Defence Association – as leading providers of professional indemnity - have also contributed to the new resources and highlighted the importance of openness and transparency in this context.

The additional toolkit for pharmacy teams includes real case studies and examples of notable practice about how pharmacy teams have learned from incidents, to improve patient safety outcomes and minimise the risk of these happening again.

All pharmacy teams are urged to use the new toolkit to prompt learning and reflection during pharmacy team meetings or other discussions. Whilst the toolkit examples are drawn from the GPhC’s inspections of community pharmacies, the professional duty to be candid applies in all sectors of pharmacy practice.

Roundtable on Duty of Candour

Chair of the GPhC, Gisela Abbam, hosted a roundtable meeting on the duty of candour on Monday (June 13), attended by the Chief Pharmaceutical Officers and organisations representing pharmacy professionals, employers and students, patients and the public and other regulators.

Gisela Abbam said: “All healthcare professionals have a duty of candour – this is a professional responsibility to be open and honest with patients when something goes wrong with their treatment or care which causes, or has the potential to cause, harm or distress.

“We know that pharmacy professionals are working in multi-disciplinary teams and taking on new clinical roles, and it’s important that they demonstrate the duty of candour in an increasing variety of complex situations.

“At our roundtable, we sought feedback on the new resources. We also discussed further actions that we can all take to make sure everyone working in pharmacy understands their responsibilities to be open and honest when things go wrong, and to improve patient safety.”

Chief executive of the GPhC, Duncan Rudkin, said: “Pharmacists and pharmacy technicians, across different settings, work hard to provide person-centred, safe and effective care to patients. But sometimes things go wrong. The way that professionals respond to these situations is key to supporting the people affected and improving patient safety for the future.

“Our new resources highlight the importance of saying sorry. Apologising to a patient does not mean that a professional is admitting legal liability for what has happened. It’s an acknowledgement that something could have gone better, and gives an opportunity for learning to improve patient safety outcomes and minimise the risk of the same thing happening again.”

Chief pharmaceutical officer for England, David Webb, said: “The duty of candour is an essential part of being a pharmacy professional in the NHS because it is fundamentally important to patients, families, carers and everyone who is involved.

“My experience is that when we take this approach, it is welcomed and engenders further trust and confidence in our professions.

“Finally, it is the way forward in terms of learning from errors and improving our systems so we continuously develop and improve.”

Chair of the Pharmacists’ Defence Association, Mark Koziol, said: “At the PDA we support the duty of candour and this new initiative by the GPhC.

“Taking a frank and honest approach is crucial, even if it means saying sorry and admitting an error has occurred.”

Head of advice and support services for the National Pharmacy Association, Jasmine Shah, said: “We are striving to move away from a blame culture towards a learning culture. It is important to acknowledge when something goes wrong and to help the patient understand what happened. What we aim for is a resolution that is supportive both of the patients and professionals involved.”

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less